Diabetes, Study | featured news

The growing toll of diabetes cost the nation a record high $245 billion in 2012, a 41% increase from $174 billion in 2007, according to new research released today. The study Economic Costs of Diabetes in the U.S. in 2012, commissioned by the American Diabetes Association, estimated the health care and work-related costs of diagnosed diabetes. The full study will be published in the April issue of Diabetes Care.

Vision loss likely related to diabetes increased by 20 percent over less than a decade in the U.S., according to a new study.

An "early and aggressive" approach to people on the cusp of developing Type 2 diabetes is needed to reduce cases of the disease, a study suggests.

For some people with diabetes, surgery may be the best medicine. Two studies have found that weight loss operations worked much better than the standard treatments to control Type 2 diabetes in obese and overweight people. Those who had surgery to staple the stomach and reroute the small intestine were much more likely to have their diabetes go into complete remission, or to need less medicine, than people given the typical regimen of drugs, diet and exercise, the studies found. The surgery also helped many to lower their blood pressure and cholesterol.

Eating processed meats and red meat regularly increases your risk of type 2 diabetes, a large new study shows.

Nearly 10 percent of the world’s adults have diabetes, and the prevalence of the disease is rising rapidly. As in the United States and other wealthy nations, increased obesity and inactivity are the primary cause in such developing countries as India and in Latin America, the Caribbean and the Middle East.

Big-box retailers Wal-Mart Stores and Kmart, pioneers in the push to cut consumer prices for generic drugs, have been raising prices for the most popular brand-name diabetes drugs, according to a new study.

Two new studies link the drug to increased heart risks just weeks before the FDA will consider whether it should remain on the market.

The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one new study linking it to an increased risk of heart attacks and a separate study linking it to an increased risk of heart failure and stroke.